Folia Medica Indonesiana
ISSN 0303-7932
Vol. 41 / No. 2 / Published : 2005-04
Order : 7, and page :108 - 117
Related with : Scholar Yahoo! Bing
Original Article :
The effectiveness test of eyedrop lodoxamide tromethamine 0.1 % and sodium cromoglycate 2% in vernal keratoconjunctivity in dr. soetomo hospital, surabaya
Author :
- Sjamsu Budiono*1
- Department of Ophthalmology Airlangga University School of Medicine Dr Soetomo Teaching Hospital, Surabaya
Abstract :
A study on the effectiveness of Lodoxamide Tromethamine 0.1% and Sodium Cromoglycate 2% has been conducted to 36 patients with vernal keratoconjunctivity in Ophthalmologic Outpatient Clinic, Dr Soetomo Hospital, Surabaya, from August 1999 to February 2000. The patients were divided into 2 groups, i.e., Lodoxamide and Cromoglycate groups. Observation was carried out at the first, second, third, and fourth weeks. From sample distribution, it was found that most of the patients (16 individuals) belonged to age group of 1 - 5 years (44.44%), followed 15 patients in age group of 6 - 10 years (41.67%). Male patients were 32 individuals or 88.89% of all patients, higher than female ones. Atopic history was 22% in children and 19.5% in family history. Regarding the type of vernal keratoconjunctivity, the combined type was found to be the most frequent compared to the others (96.11%). Most of the samples (52.78%) suffered from vernal keratoconjunctivity for less than 1 year. Results of observation revealed significant difference in therapy effectiveness between eyedrops Lodoxamide Tromethamine 0.1% and Sodium Cromoglycate 2% in subjective complaints/symptoms (such as itch, secrete, epiphora) and objective complaints/sign (hyperemia and conjunctival edema, corneal lesion), which was varied from the first to the third week, while at the fourth week the difference was not significant. There was no significant difference in therapy effectiveness between both eyedrops in the objective symptoms (trantas dots and laboratory test). Comparative analysis on the objective symptoms (papillary hypertrophy) between both groups could not be conducted. However, significant difference was found in group given with Lodoxamide Tromethamine 0.1% before and fourth week after treatment. In group given with Sodium Cromoglycate 2%, significant difference was not found until the study was over. Side effects of the treatment were not apparent during the study.
Keyword :
lodoxamide tromethamine, sodium cromoglycate, vernal keratoconjunctivity,
References :
Allansmith MR,(1982) The Eye and Immunology London : The CV Mosby Company
David DD,(1968) Atlas of External Disease of the Eye St. Louis : The CV Mosby Company
Archive Article
Cover Media | Content |
---|---|
Volume : 41 / No. : 2 / Pub. : 2005-04 |
|